SEC Form D private-offering filing

MultiValent Biotherapies, Inc.

Name: MultiValent Biotherapies, Inc. - new SEC Form D private-offering filing, Los Altos, CA
Published: 2026-03-02

A new SEC Form D private-offering notice from Los Altos, CA, an undisclosed offering target in Biotech. The source filing is one click away.

MultiValent Biotherapies, Inc. site↗ Verified via SEC Form D

A biotechnology company developing targeted peptide drug conjugate therapies for cancer, including a prostate cancer treatment licensed from Coherent Biopharma.

Filed 2026-03-02Filed to raise UndisclosedFirst money in 2026-01-09Raised so far $10,012,500HQ (as filed) Los Altos, CASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified multivalentbiotherapies.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.